Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP925032.RAockD73q9xyU9mLD1dp_--bTRsFsZrIMSfOam2H8Jn3A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP925032.RAockD73q9xyU9mLD1dp_--bTRsFsZrIMSfOam2H8Jn3A130_assertion type Assertion NP925032.RAockD73q9xyU9mLD1dp_--bTRsFsZrIMSfOam2H8Jn3A130_head.
- NP925032.RAockD73q9xyU9mLD1dp_--bTRsFsZrIMSfOam2H8Jn3A130_assertion description "[A synergistic association of PIK3CA mutation with KRAS mutation has been suggested to increase AKT signaling and resistance to antiepidermal growth factor receptor inhibitor therapy for advanced colorectal cancer, although studies have been conflicting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925032.RAockD73q9xyU9mLD1dp_--bTRsFsZrIMSfOam2H8Jn3A130_provenance.
- NP925032.RAockD73q9xyU9mLD1dp_--bTRsFsZrIMSfOam2H8Jn3A130_assertion evidence source_evidence_literature NP925032.RAockD73q9xyU9mLD1dp_--bTRsFsZrIMSfOam2H8Jn3A130_provenance.
- NP925032.RAockD73q9xyU9mLD1dp_--bTRsFsZrIMSfOam2H8Jn3A130_assertion SIO_000772 21932420 NP925032.RAockD73q9xyU9mLD1dp_--bTRsFsZrIMSfOam2H8Jn3A130_provenance.
- NP925032.RAockD73q9xyU9mLD1dp_--bTRsFsZrIMSfOam2H8Jn3A130_assertion wasDerivedFrom befree-2016 NP925032.RAockD73q9xyU9mLD1dp_--bTRsFsZrIMSfOam2H8Jn3A130_provenance.
- NP925032.RAockD73q9xyU9mLD1dp_--bTRsFsZrIMSfOam2H8Jn3A130_assertion wasGeneratedBy ECO_0000203 NP925032.RAockD73q9xyU9mLD1dp_--bTRsFsZrIMSfOam2H8Jn3A130_provenance.